Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for evaluating and treating hypertension

a hypertension and hypertension technology, applied in the direction of instruments, catheters, diagnostic recording/measuring, etc., can solve the problem of conceptually flawed step-care approaches, and achieve the effect of rational drug selection and improved therapeutic success ra

Inactive Publication Date: 2005-04-28
LARAGH JOHN H
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0008] The present invention discussed herein provides novel methods or systems—the Laragh Method—for evaluating and treating hypertensive patients. The Laragh Method provides a systematic approach that allows physicians and other health care providers to select the appropriate treatment, tailored to suit each individual hypertensive patient. The Laragh Method greatly improves the therapeutic success rate among hypertensive patients and uses more rational drug selection as compared to the traditional, empirical “stepped care” approach.

Problems solved by technology

The stepped care approach is conceptually flawed because it fails to recognize the heterogeneity of biochemical mechanisms involved among different hypertensive patients.
Just as fever cannot be appropriately treated with a single recipe, neither should hypertension.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] FIG. 1 is a schematic illustration of the renin-angiotensin-aldosterone system. The normal function of this system is generally believed to raise blood pressure when it is too low and thus maintain blood pressure during upright posture and exercise or during periods of dehydration or salt loss. However, excessive kidney renin secretion, leading to higher plasma renin levels, is associated with hypertension, heart attack, stroke, and other cardiovascular disease.

Mechanisms of Blood Pressure Control and Antihypertensive Drugs

[0021] Blood pressure is determined to a large extent by a combination of two factors: the size of the blood volume and the degree of constriction of arterioles, small muscular blood vessels at the periphery of the vasculature. Blood volume is determined largely by the amount of sodium in the body, which osmotically retains fluid in the body and thereby enlarges the blood volume. The constriction of arterioles is controlled by several factors, the most i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Massaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

The Laragh Method is a novel method useful for evaluating and treating hypertensive patients. The Laragh Method provides a systematic approach for the physician to use volume vasoconstriction information with entry and induced changes in blood pressure and in ambulatory plasma renin levels for the rational selection of treatment tailored to suit each individual hypertensive patient. The Laragh Method provides a systematic and rational approach to drug selection which greatly improves the therapeutic success rate among hypertensive patients and which for the large majority provides long-term blood pressure control with one drug instead of two or two instead of three with each drug rationally targeted to control the renin and / or volume elements in the blood pressure equation.

Description

FIELD OF THE INVENTION [0001] The present invention relates to new and useful methods for the evaluation and treatment of hypertension. BACKGROUND INFORMATION [0002] Hypertension is a sustained elevation of blood pressure that can lead to heart attack, heart or kidney failure, stroke, and other cardiovascular diseases. Hypertension affects about 20% of the population worldwide. A major problem is that the current methods that are widely used for the detection and treatment of hypertension are inadequate and result in enormous personal suffering and economic costs. The Economic Costs of Hypertension [0003] The 1999 Annual Report of the American Heart Association estimates the direct cost of hypertension in the United States to be $26.1 billion annually, plus an additional $11.1 billion in indirect costs arising from lost productivity due to morbidity and mortality (Table 1). Moreover, the link between hypertension and other cardiovascular diseases has become increasingly evident. T...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/166G01N33/50A61K31/341A61K31/401A61K31/417A61K31/4422A61P9/12G01N33/15G01N33/53G01N33/68G16H20/10G16H40/63
CPCG01N33/6893G01N2800/321G01N2800/324G06F19/366G06F19/3456G06F19/3481G01N2800/52G16H10/40A61P9/12G16H40/63G16H20/10
Inventor LARAGH, JOHN H.
Owner LARAGH JOHN H
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products